Optimal management of hormone receptor positive metastatic breast cancer in 2016
Hormone receptor positive tumors represent the most common form of breast cancer and account for most of the deaths from the disease. Endocrine therapy represents the main initial therapeutic strategy for these patients and has been associated with significant clinical benefits in a majority of pati...
Main Authors: | Tomas Reinert, Carlos H. Barrios |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2015-11-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834015608993 |
Similar Items
-
Overall survival and progression-free survival with endocrine therapy for hormone receptor-positive, HER2-negative advanced breast cancer: review
by: Tomás Reinert, et al.
Published: (2017-11-01) -
Efficacy of chemotherapy after hormone therapy for hormone receptor–positive metastatic breast cancer
by: Ryutaro Mori, et al.
Published: (2014-11-01) -
Overcoming endocrine resistance in metastatic hormone receptor-positive breast cancer
by: Anishka D’Souza, et al.
Published: (2018-06-01) -
Estimation of the Number of Brazilian Women Living With Metastatic Breast Cancer
by: Tomás Reinert, et al.
Published: (2020-11-01) -
Determination and clinical significance of bone pseudoprogression in hormone receptor-positive metastatic breast cancer
by: Mingxi Lin, et al.
Published: (2021-06-01)